Mobilized Peripheral Blood Mononuclear Cells, Plerixafor, Frozen

Mobilized Human Peripheral Blood Mononuclear Cells (MNCs) are isolated from donors injected with 240μg/kg of Plerixafor® (aka Mozobil) the day before collection. Isolated MNCs are characterized by flow cytometry to ensure a highly enriched and viable cell population.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies.  By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

CGT Global - Landing Page Desktop Prototype

Description

Mobilized Human Peripheral Blood Mononuclear Cells (MNCs) are isolated from donors injected with 240μg/kg of Plerixafor® (aka Mozobil) the day before collection. Isolated MNCs are characterized by flow cytometry to ensure a highly enriched and viable cell population.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Additional information

Weight N/A
Anticoagulant

Format

Grade

Species

Cell and Tissue Source

Disease State

Donor Attributes

Product Information Sheet

Mobilized Mononuclear Cells, Plerixafor – Frozen

Material Safety Data Sheet

Mobilized MNCs – Frozen